Company Filing History:
8 out of 575 
1 out of 22 
1 out of 4,945 
Years Active: 2017-2025
Title: The Innovative Contributions of Tomoko Yasuhiro
Introduction
Tomoko Yasuhiro is a prominent inventor based in Osaka, Japan. She has made significant contributions to the field of cancer treatment through her innovative research and development of therapeutic agents. With a total of nine patents to her name, Yasuhiro's work focuses on combination therapies that enhance the efficacy of cancer treatments.
Latest Patents
Yasuhiro's latest patents include groundbreaking inventions aimed at improving cancer therapies. One notable patent is for a combination therapy of an anti-CD20 antibody with a BTK inhibitor. This invention targets CD20 expressing cancers and utilizes a type I anti-CD20 antibody or an afucosylated humanized B-Ly1 antibody in conjunction with a BTK inhibitor. Another significant patent involves a therapeutic agent for solid cancers, which comprises an Axl inhibitor as the active ingredient. This agent includes a specific compound that demonstrates strong antitumor effects, making it a valuable option for treating solid tumors.
Career Highlights
Throughout her career, Tomoko Yasuhiro has worked with notable companies, including Ono Pharmaceutical Co., Ltd. and Ono Pharmaceuticals Co., Ltd. Her experience in these organizations has allowed her to develop and refine her innovative ideas, contributing to advancements in cancer treatment.
Collaborations
Yasuhiro has collaborated with esteemed colleagues in her field, including Takayuki Inukai and Jun Takeuchi. These partnerships have fostered a collaborative environment that enhances the development of effective cancer therapies.
Conclusion
Tomoko Yasuhiro's contributions to cancer treatment through her innovative patents and collaborations highlight her significant role in the field. Her work continues to pave the way for advancements in therapeutic options for patients battling cancer.